CRISPR Therapeutics AG logo
CRISPR Therapeutics AG CRSP
$ 56.6 -0.14%

Quarterly report 2025-Q3
added 11-10-2025

report update icon

CRISPR Therapeutics AG Net Debt 2011-2025 | CRSP

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt CRISPR Therapeutics AG

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-74.6 M -151 M 32.1 M -698 M - -891 M -457 M -240 M -316 M -118 M -945 K - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
32.1 M -891 M -291 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Biotechnology industry

Issuer Net Debt Price % 24h Market Cap Country
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-107 M $ 4.9 4.03 % $ 813 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
163 M - 2.43 % $ 254 M germanyGermany
Aclaris Therapeutics Aclaris Therapeutics
ACRS
-22 M $ 3.21 -1.38 % $ 248 M usaUSA
AlloVir AlloVir
ALVR
-62.7 M - 4.14 % $ 49.1 M usaUSA
Aptevo Therapeutics Aptevo Therapeutics
APVO
-3.28 M $ 1.06 -6.22 % $ 293 K usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
-33.1 M $ 13.33 -5.39 % $ 878 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
-402 M - - $ 40.3 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-195 M $ 214.55 -2.66 % $ 5 B danmarkDanmark
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-824 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-6.17 M - -18.52 % $ 27.3 M britainBritain
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
-34.7 M $ 3.1 -5.93 % $ 7.46 B australiaAustralia
Celldex Therapeutics Celldex Therapeutics
CLDX
-24.5 M $ 27.09 -1.53 % $ 1.74 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
-121 M $ 88.51 0.59 % $ 9.14 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
-514 M $ 24.35 3.07 % $ 2.88 B usaUSA
Biophytis SA Biophytis SA
BPTS
-4.01 M - -13.47 % $ 169 M franceFrance
CureVac N.V. CureVac N.V.
CVAC
-783 M $ 5.02 -0.59 % $ 934 M germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
246 M - - - russiaRussia
BioVie BioVie
BIVI
-17.2 M $ 1.43 -1.72 % $ 2.11 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
-60.6 M - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-27.4 M - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
-119 M - -15.15 % $ 60.3 M britainBritain
BioNTech SE BioNTech SE
BNTX
-973 M $ 93.99 -0.86 % $ 27.2 B germanyGermany
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-30.2 M - - $ 1.01 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
-65.3 M $ 10.88 0.74 % $ 1.41 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
-239 M - -0.23 % $ 916 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
-63.9 M - - $ 2.17 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-12 M - -11.43 % $ 502 K usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
469 M $ 26.44 4.63 % $ 1.28 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
-56.5 M - - $ 10.1 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
-46 M $ 9.6 0.42 % $ 141 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
-10.8 M $ 15.97 -4.37 % $ 410 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
-3.5 M $ 0.26 -6.9 % $ 566 M israelIsrael
Evogene Ltd. Evogene Ltd.
EVGN
-3.44 M $ 1.04 -3.7 % $ 27.9 M israelIsrael
Exelixis Exelixis
EXEL
-1.54 M $ 41.27 0.95 % $ 12 B usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
-25.4 M - -6.81 % $ 3.04 B usaUSA
Athersys Athersys
ATHX
-27.6 M - 3.77 % $ 22.4 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-2.08 M - 2.71 % $ 14 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-3.13 K - -52.27 % $ 4.45 M usaUSA
Foghorn Therapeutics Foghorn Therapeutics
FHTX
-18.3 M $ 4.39 -1.13 % $ 241 M usaUSA
AVROBIO AVROBIO
AVRO
-76.6 M - 1083.1 % $ 745 M usaUSA
Axon Enterprise Axon Enterprise
AXON
-404 M $ 551.37 -2.29 % $ 41.8 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-657 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
-19.9 M $ 2.35 2.17 % $ 14.8 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
9.86 B $ 91.19 1.51 % $ 96.9 B britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
114 M - -24.86 % $ 820 K usaUSA
Brickell Biotech Brickell Biotech
BBI
-29.7 M - -5.38 % $ 6.06 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
-135 M $ 8.88 -1.33 % $ 1.45 B britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
-2.44 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
455 M $ 11.25 -2.43 % $ 728 M usaUSA
Biogen Biogen
BIIB
4.01 B $ 174.69 0.34 % $ 25.4 B usaUSA